Universe Pharmaceuticals (UPC) Retained Earnings (2020 - 2025)

Universe Pharmaceuticals has disclosed Retained Earnings across 6 years of filings, most recently posting -$1.8 billion for Q3 2025.

• Retained Earnings for Q3 2025 came in at -$1.8 billion, up 82.17% year-over-year; the trailing twelve-month figure through Sep 2025 was -$1.8 billion (up 82.17% YoY), and the FY2025 annual result was -$1.8 billion, up 82.17% from the prior year.
• Retained Earnings came in at -$1.8 billion for Q3 2025 at Universe Pharmaceuticals, up from -$10.2 billion in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $26.8 million in Q1 2022 to a low of -$10.2 billion in Q3 2024.
• The 5-year median for Retained Earnings is -$1.6 million (2022), against an average of -$1.5 billion.
• Across the five-year window, Retained Earnings plunged 704170.53% in 2024 and soared 82.17% in 2025, its largest moves.
• Universe Pharmaceuticals' Retained Earnings stood at $2.1 million in 2021, then plunged by 179.79% to -$1.7 million in 2022, then rose by 13.35% to -$1.4 million in 2023, then slumped by 704170.53% to -$10.2 billion in 2024, then jumped by 82.17% to -$1.8 billion in 2025.
• The last three Retained Earnings figures came in at -$1.8 billion (Q3 2025), -$10.2 billion (Q3 2024), and -$2.1 million (Q1 2024), per Business Quant data.